These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 7125430)
21. [Comparative effects of probucol and placebo on blood cholesterol in patients on long-term treatment (author's transl)]. Mc Caughan D Nouv Presse Med; 1980 Oct; 9(40):3018-20. PubMed ID: 7443444 [TBL] [Abstract][Full Text] [Related]
30. [Effect of cholestyramine and chenodesoxycholic acid on liver cirrhosis. An experimental study in rats]. de Heer K; Werner B; Sauer HD; Klöppel G Z Exp Chir; 1980 Apr; 13(2):105-13. PubMed ID: 7445625 [TBL] [Abstract][Full Text] [Related]
31. [The effects of probucol in man (author's transl)]. Leutenegger M Nouv Presse Med; 1980 Oct; 9(40):2985-9. PubMed ID: 7443436 [TBL] [Abstract][Full Text] [Related]
32. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia. Magill P; Whiting C; Hammett F; Glick I; Miller NE; Lewis B Artery; 1982; 10(2):88-94. PubMed ID: 7092581 [TBL] [Abstract][Full Text] [Related]
33. [Pharmacology of probucol. I]. Donatelli L Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074 [No Abstract] [Full Text] [Related]
34. [New derivatives of clofibrate and probucol. Preliminary study of their hypolipemic activity]. de Meglio P; Ravenna F; Manzardo S; Gentili P; Riva M Farmaco Sci; 1985 Nov; 40(11):833-44. PubMed ID: 4085644 [TBL] [Abstract][Full Text] [Related]
35. Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia. LeLorier J; DuBreuil-Quidoz S; Lussier-Cacan S; Huang YS; Davignon J Arch Intern Med; 1977 Oct; 137(10):1429-34. PubMed ID: 335998 [TBL] [Abstract][Full Text] [Related]
36. Probucol reduces the rate of association of apolipoprotein C-III with dimyristoylphosphatidylcholine. McLean LR; Hagaman KA Biochim Biophys Acta; 1988 Apr; 959(3):201-5. PubMed ID: 3355846 [TBL] [Abstract][Full Text] [Related]
37. Effects of probucol on lipoprotein protein kinetics. Nestel PJ Artery; 1982; 10(2):95-8. PubMed ID: 7092582 [TBL] [Abstract][Full Text] [Related]
38. The role of oxidized lipoproteins in the pathogenesis of atherosclerosis. Kita T; Yokode M; Ishii K; Kume N; Nagano Y; Arai H; Otani H; Ueda Y; Hara S Clin Exp Pharmacol Physiol Suppl; 1992; 20():37-42. PubMed ID: 1446408 [TBL] [Abstract][Full Text] [Related]
39. Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias. Beaumont JL; Jacotot B; Buxtorf JC; Silvestre M; Beaumont V Artery; 1982; 10(1):71-87. PubMed ID: 7092577 [TBL] [Abstract][Full Text] [Related]
40. Use of a human microvascular endothelial cell line as a model system to evaluate cholesterol uptake. Pruckler JM; Lawley TJ; Ades EW Pathobiology; 1993; 61(5-6):283-7. PubMed ID: 8297494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]